News for TG Therapeutics Stock (TGTX)

SHAREHOLDER ACTON REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/15/22

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/13/22

Can TG Therapeutics (TGTX) Climb 193% to Reach the Level Wall Street Analysts Expect?

Zacks Investment Research • 08/12/22

INVESTOR ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/11/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action

Newsfile Corp • 08/10/22

INVESTOR ACTON REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/10/22

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/09/22

TGTX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving TG Therapeutics, Inc.

Newsfile Corp • 08/09/22

INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/09/22

TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call Transcript

Seeking Alpha • 08/08/22

TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results

GlobeNewsWire • 08/08/22

ROSEN, A TOP RANKED LAW FIRM, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/05/22

SHAREHOLDER ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/05/22

TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update

GlobeNewsWire • 08/05/22

TG THERAPEUTICS INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against TG Therapeutics Inc. (NASDAQ: TGTX); Lead Plaintiff Deadline is September 16 2022

PRNewsWire • 08/04/22

TGTX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Class Action Pending

Newsfile Corp • 08/04/22

Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm

Newsfile Corp • 08/03/22

TGTX ALERT: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Class Action Filed

PRNewsWire • 08/03/22

ROSEN, National Trial Lawyers, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/02/22

TGTX Shareholder News: Robbins LLP is Investigating TG Therapeutics, Inc. (TGTX) on Behalf of Shareholders

Business Wire • 08/01/22

ROSEN, Leading Investor Counsel, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 07/28/22

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 07/23/22

TGTX Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

Business Wire • 07/22/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

PRNewsWire • 07/22/22

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

Business Wire • 07/20/22